Effective delivery systems including needles, syringes, auto-injectors, and containment vialsare critical for patient adherence, dosing accuracy, and safety
Researchers concluded, Our main finding is that prescribed semaglutide is associated with an increased risk of NAION. Diabetic patients who took semaglutide were more than four times more likely to develop NAION than those on non-GLP-1 medications
The proposed mechanism is two-fold: transplanted mitochondria can directly supply ATP to energy-starved cells and can also modulate immune cells by reducing DAMPs release and apoptosis
Are you taking other medications that might interact with GLP-1s or require monitoring
Like all medications, GLP-1s come with potential side effects
What to Look for in Your Supplements Not all supplements are created equal